595 filings
Page 2 of 30
8-K
bjpr1di21 88
22 Dec 22
Regulation FD Disclosure
4:21pm
8-K
wf2pvhzx
28 Nov 22
Entry into a Material Definitive Agreement
4:05pm
8-K
3dx1n
15 Nov 22
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023
12:36pm
8-K
dtvmu42o
10 Nov 22
Termination of a Material Definitive Agreement
4:15pm
8-K
f5h7sv4d4i6fm
2 Nov 22
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
4:30pm
8-K
okjhd
7 Sep 22
Entry into a Material Definitive Agreement
4:35pm
8-K
wh9nn
26 Aug 22
Termination of a Material Definitive Agreement
4:45pm
8-K
n3tpscyt42ekcd
15 Aug 22
Results of Operations and Financial Condition
6:14pm
8-K
qjaps purhdavq9qzv0
29 Jun 22
Results of Operations and Financial Condition
5:03pm
8-K
0k69kn2nav m8
29 Jun 22
Regulation FD Disclosure
9:00am
8-K
2tf 0k8wm97k
11 May 22
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
5:13pm
8-K
kp9590sh9rq8m0n5w
18 Apr 22
Departure of Directors or Certain Officers
4:35pm
8-K
gq1l glsr
4 Apr 22
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
11:26am
8-K
lphky 0cw1q9h2va
15 Feb 22
Results of Operations and Financial Condition
12:00am
8-K
xzuo ysqlsyikf
9 Dec 21
Entry into a Material Definitive Agreement
10:47am